Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies
- 1 December 1994
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 68 (12), 8350-8364
- https://doi.org/10.1128/jvi.68.12.8350-8364.1994
Abstract
The reactivities of a panel of 14 monoclonal antibodies (MAbs) with monomeric gp120 derived from 67 isolates of human immunodeficiency virus type 1 of clades A through F were assessed by using an antigen-capture enzyme-linked immunosorbent assay. The MAbs used were all raised against gp120 or gp120 peptides from clade B viruses and were directed at a range of epitopes relevant to human immunodeficiency virus type 1 neutralization: the V2 and V3 loops, discontinuous epitopes overlapping the CD4-binding site, and two other discontinuous epitopes. Four of the five V3 MAbs showed modest cross-reactivity within clade B but very limited reactivity with gp120s from other clades. These reactivity patterns are consistent with the known primary sequence requirements for the binding of these MAbs. One V3 human MAb (19b), however, was much more broadly reactive than the others, binding to 19 of 29 clade B and 10 of 12 clade E gp120s. The 19b epitope is confined to the flanks of the V3 loop, and these sequences are relatively conserved in clade B and E viruses. In contrast to the limited reactivity of V3 MAbs, CD4-binding site MAbs were much more broadly reactive across clades, two of these MAbs (205-46-9 and 21h) being virtually pan-reactive across clades A through F. Another human MAb (A-32) to a discontinuous epitope was also pan-reactive. The CD4-binding site is strongly conserved between clades; but when considering the epitopes near the CD4-binding site, clade D gp120 appears to be the most closely related to clade B and clade E appears to be the least related. A tentative rank order for these epitopes is B/D-A/C-E/F. V2 MAbs reacted sporadically within and between clades, and no clear pattern was observable. While results from binding assays do not predict neutralization serotypes, they suggest that there may be antigenic subtypes related, but not identical, to the genetic subtypes.Keywords
This publication has 58 references indexed in Scilit:
- Diversity of V3 Region Sequences of Human Immunodeficiency Viruses Type 1 from the Central African RepublicAIDS Research and Human Retroviruses, 1993
- A Potent, Neutralizing Human Monoclonal Antibody against a Unique Epitope Overlapping the CD4-Binding Site of HIV-1 gp120 That Is Broadly Conserved across North American and African Virus IsolatesAIDS Research and Human Retroviruses, 1993
- V3 Loops of HIV-1 Specimens from Pregnant Women in Malawi Uniformly Lack a Potential N-Linked Glycosylation SiteAIDS Research and Human Retroviruses, 1993
- Sequence Analysis of the gp120 Region of theenvGene of Ugandan Human Immunodeficiency Proviruses from a Single IndividualAIDS Research and Human Retroviruses, 1993
- Molecular Profile of an Antibody Response to HIV-1 as Probed by Combinatorial LibrariesJournal of Molecular Biology, 1993
- Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The NetherlandsAIDS, 1993
- The Reactivities of HIV-1+Human Sera with Solid-Phase V3 Loop Peptides Can Be Poor Predictors of Their Reactivities with V3 Loops on Native gp120 MoleculesAIDS Research and Human Retroviruses, 1993
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1AIDS, 1989
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986